查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1464658

診斷放射性同位素市場，按放射性同位素、按應用、按成像方式、按最終用戶、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Diagnostic Radioisotopes Market, By Radioisotope, By Application, By Imaging Modality, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年診斷放射性同位素市場規模為58.2021億美元，2024年至2032年年複合成長率為9.81%。

診斷放射性同位素市場-市場動態

慢性病盛行率上升預計將推動市場成長

癌症、心臟病和神經系統疾病等慢性疾病通常需要頻繁的診斷影像來監測疾病進展、評估治療效果和識別復發。診斷放射性同位素在正子斷層掃描 (PET)、單光子發射電腦斷層掃描 (SPECT) 和伽馬相機成像等各種影像技術中至關重要，有助於慢性疾病的精確診斷和分期。根據美國國家衛生統計中心的數據，慢性病是指持續三個月或更長的疾病。大約 4000 萬美國人由於一種或多種慢性健康狀況而導致日常活動受到限制。混合成像技術的日益普及為市場帶來了成長機會。然而，生產和基礎設施的高成本可能會阻礙市場成長。

診斷放射性同位素市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 9.81% 左右的年複合成長率成長

根據放射性同位素細分，預計 Technetium-99m 將在 2023 年顯示最大的市場佔有率

從應用細分來看，腫瘤學是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

診斷放射性同位素市場細分分析：

全球診斷放射性同位素市場根據放射性同位素、應用、成像方式、最終用戶和地區進行細分。

根據放射性同位素，市場分為五個部分：Technetium-99m、鉈-201、鎵-67、碘-123、FDG、銣-82 等。 Technetium-99m 在市場上佔有最大佔有率。 Technetium-99m (Tc-99m) 是一種在核醫學診斷影像中廣泛使用的放射性同位素。

根據應用，市場分為兩類：腫瘤學、心臟病學和其他。腫瘤學在市場上佔有最大佔有率。診斷放射性同位素在腫瘤學中使用的不同影像技術中至關重要，有助於腫瘤檢測和表徵、疾病進展評估和治療反應評估。

根據影像模式，市場分為三類：SPECT、PET 和 Beta 發射器。每種影像方式都使用不同的放射性同位素來觀察體內的生物過程和結構，有助於癌症等不同疾病的診斷、分期、治療計劃和監測。

根據最終用戶，市場分為四類：醫院、專科診所、診斷中心、學術和研究機構以及其他機構。每個最終用戶群體對利用放射性同位素的診斷成像服務都有獨特的需求和需求。

診斷放射性同位素市場 - 地理洞察

該市場在地理上廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據參與商業活動的國家進一步分類。市場的成長預計將由北美推動，主要是由於核醫學投資的增加。鼓膜造口產品市場主要集中於耳部感染的治療和相關耳鼻喉科手術，而核子醫學則以放射性同位素的醫學影像和診斷為中心。在美國，每年進行超過 2,000 萬例核醫手術，而在歐洲，這一數字約為 1,000 萬例，其中 200 萬例為治療性手術。展望未來，歐洲預計將成為市場成長的驅動力，這主要歸功於診斷成像方式的進步。

診斷放射性同位素市場-競爭格局：

診斷放射性同位素市場的特點是競爭激烈，各公司努力確保穩定可靠的高品質放射性同位素供應。他們還專注於提供高效的影像解決方案，遵守安全和監管準則，並促進創新，以滿足醫療保健專業人員和患者不斷變化的需求。此外，該市場的競爭圍繞著放射性製藥公司提供的放射性同位素產品的品質、可靠性和品種。我們也追求技術進步，以提高生產效率、降低成本並確保符合安全和監管標準。

最近的發展：

西門子 Healthineers 宣布決定關閉其 Fast Track Diagnostics 部門，該部門是診斷業務的一個部門，提供聚合酶鏈反應 (PCR) 檢測產品。這個特殊的產品組合主要在歐洲銷售。自 COVID-19 大流行高峰以來，對這些產品的需求已大幅下降。

醫學影像的另一個進展是正子斷層掃描 (PET)，這是一種利用迴旋加速器中產生的同位素的高精度和先進技術。透過引入正電子發射放射性核素（通常透過注射），它會積聚在目標特定組織中。

目錄

第 1 章：診斷放射性同位素市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 放射性同位素診斷放射性同位素市場片段
    • 按應用分類的診斷放射性同位素市場片段
    • 按成像方式分類的診斷放射性同位素市場片段
    • 最終用戶的診斷放射性同位素市場片段
    • 按國家/地區分類的診斷放射性同位素市場片段
    • 按地區分類的診斷放射性同位素市場片段
  • 競爭洞察

第 3 章：診斷放射性同位素主要市場趨勢

  • 診斷放射性同位素市場促進因素
    • 市場促進因素的影響分析
  • 診斷放射性同位素市場限制
    • 市場限制影響分析
  • 診斷放射性同位素市場機會
  • 診斷放射性同位素市場未來趨勢

第 4 章：診斷放射性同位素產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：診斷放射性同位素市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：診斷放射性同位素市場格局

  • 2023 年診斷放射性同位素市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：診斷放射性同位素市場 - 按放射性同位素

  • 概述
    • 按放射性同位素分類的細分市佔率分析
    • 锝-99m
    • 鉈201
    • 鎵67
    • 碘123
    • 脫氧葡萄糖
    • 銣82
    • 其他

第 8 章：診斷放射性同位素市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 腫瘤學
    • 心臟病學
    • 其他

第 9 章：診斷放射性同位素市場 - 依影像方式

  • 概述
    • 按成像方式分類的細分市場佔有率分析
    • SPECT
    • 寵物
    • 貝塔發射器

第 10 章：診斷放射性同位素市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 專科診所
    • 診斷中心
    • 學術及研究機構
    • 其他

第 11 章：診斷放射性同位素市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美診斷放射性同位素主要製造商
    • 北美市場規模和預測（按國家）
    • 北美洲市場規模與預測（按放射性同位素）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按成像方式）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲診斷放射性同位素主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲放射性同位素市場規模與預測
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按成像方式）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區診斷放射性同位素主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區放射性同位素市場規模與預測
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模與預測（依影像方式）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲診斷放射性同位素主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按放射性同位素）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模與預測（以成像方式）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲診斷放射性同位素主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按放射性同位素）
    • 中東和非洲市場規模及預測（按應用）
    • 中東及非洲市場規模及預測（依影像方式）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 診斷放射性同位素產業

  • 競爭儀表板
  • 公司簡介
    • GE Healthcare
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Cardinal Health
    • Lantheus Holdings, Inc.
    • Bayer AG
    • Bracco
    • Eckert & Ziegler
    • Nordion (Canada) Inc.
    • NTP Radioisotopes
    • Curium, Jubilant Life Sciences Ltd
    • Isotopia Molecular Imaging Ltd.
    • Mallinckrodt Nuclear Medicine LLC
    • Jubilant DraxImage Inc.
    • Sumitomo Heavy Industries, Ltd.
    • Telix Pharmaceuticals Limited
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2460

REPORT HIGHLIGHT

Diagnostic Radioisotopes Market size was valued at USD 5,820.21 Million in 2023, expanding at a CAGR of 9.81% from 2024 to 2032.

Diagnostic radioisotopes are radioactive isotopes that are employed in medical imaging for the purpose of diagnosing various medical conditions and diseases. These particular radioisotopes emit gamma rays, which can be detected by specialized imaging equipment like gamma cameras or PET scanners. The administration of these radioisotopes to patients is typically done through oral ingestion, intravenous injection, or inhalation, depending on the specific imaging procedure and the organ or tissue under examination. Despite their radioactive nature, the doses utilized in diagnostic imaging are extremely small and are considered safe for patients. In fact, the advantages of diagnostic imaging with radioisotopes often outweigh the potential risks associated with radiation exposure.

Diagnostic Radioisotopes Market- Market Dynamics

Rising Prevalence of Chronic Diseases is anticipated to propel the market growth

Chronic illnesses like cancer, heart diseases, and neurological disorders often necessitate frequent diagnostic imaging for monitoring disease progression, evaluating treatment effectiveness, and identifying recurrence. Diagnostic radioisotopes are essential in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma camera imaging, facilitating precise diagnosis and staging of chronic illnesses. According to the U.S. National Center for Health Statistics, a chronic disease is one that lasts for three months or more. Approximately 40 million Americans have limitations in their daily activities due to one or more chronic health conditions. The increasing adoption of hybrid imaging technologies presents a growth opportunity for the market. However, the high cost of production and infrastructure may hinder market growth.

Diagnostic Radioisotopes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.81% over the forecast period (2024-2032)

Based on Radioisotope segmentation, Technetium-99m was predicted to show maximum market share in the year 2023

Based on application segmentation, Oncology was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Diagnostic Radioisotopes Market- Segmentation Analysis:

The Global Diagnostic Radioisotopes Market is segmented on the basis of Radioisotope, Application, Imaging Modality, End-user and Region.

The market is segmented into five divisions according to Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others. Technetium-99m holds the largest share in the market. Technetium-99m (Tc-99m) is a highly utilized radioisotope in nuclear medicine for diagnostic imaging.

The market is segmented into two categories according to application: Oncology, Cardiology, and Other. Oncology holds the largest share in the market. Diagnostic radioisotopes are crucial in different imaging techniques utilized in oncology, assisting in tumor detection and characterization, disease progression assessment, and treatment response evaluation.

The market is segmented into three categories according to Imaging Modality: SPECT, PET, and Beta Emitters. Each imaging modality uses distinct radioisotopes to observe biological processes and structures in the body, aiding in the diagnosis, staging, treatment planning, and monitoring of different diseases, such as cancer.

The market is segmented into four categories according to End-user: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Other establishments. Each end-user group has unique needs and demands for diagnostic imaging services that make use of radioisotopes.

Diagnostic Radioisotopes Market- Geographical Insights

This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be driven by North America, primarily due to increasing investments in nuclear medicine. The Tympanostomy Products market mainly focuses on the treatment of ear infections and related otolaryngology procedures, while nuclear medicine is centered around medical imaging and diagnosis using radioisotopes. In the United States, there are over 20 million nuclear medicine procedures conducted annually, while in Europe, the number is around 10 million, with 2 million of them being therapeutic procedures. Looking ahead, Europe is projected to be the driving force behind the market's growth, mainly due to advancements in diagnostic imaging modalities.

Diagnostic Radioisotopes Market- Competitive Landscape:

The Diagnostic Radioisotopes Market is characterized by intense competition, with companies striving to ensure a steady and dependable supply of high-quality radioisotopes. They also focus on providing efficient imaging solutions, adhering to safety and regulatory guidelines, and fostering innovation to meet the evolving needs of healthcare professionals and patients. Additionally, competition in this market revolves around the quality, reliability, and variety of radioisotope products offered by radio pharmaceutical companies. Technological advancements are also pursued to improve production efficiency, lower costs, and ensure compliance with safety and regulatory standards.

Recent Developments:

Siemens Healthineers has announced its decision to close down its Fast Track Diagnostics unit, a division within the Diagnostics business that offers polymerase chain reaction (PCR) testing products. This particular portfolio is primarily sold in Europe. The demand for these products has significantly declined since the peak of the COVID-19 pandemic.

Another advancement in medical imaging is positron emission tomography (PET), a highly accurate and advanced technique that utilizes isotopes generated in a cyclotron. By introducing a positron-emitting radionuclide, typically through injection, it accumulates in the specific tissue being targeted.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GE Healthcare

Siemens Healthineers

Koninklijke Philips N.V.

Cardinal Health

Lantheus Holdings, Inc.

Bayer AG

Bracco

Eckert & Ziegler

Nordion (Canada) Inc.

NTP Radioisotopes

Curium, Jubilant Life Sciences Ltd

Isotopia Molecular Imaging Ltd.

Mallinckrodt Nuclear Medicine LLC

Jubilant DraxImage Inc.

Sumitomo Heavy Industries, Ltd.

Telix Pharmaceuticals Limited

Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY RADIOISOTOPE- MARKET ANALYSIS, 2019 - 2032

  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • FDG
  • Rubidium-82
  • Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiology
  • Other

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY IMAGING MODALITY- MARKET ANALYSIS, 2019 - 2032

  • SPECT
  • PET
  • Beta Emitters

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Diagnostic Radioisotopes Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Diagnostic Radioisotopes Market Snippet by Radioisotope
    • 2.1.2.Diagnostic Radioisotopes Market Snippet by Application
    • 2.1.3.Diagnostic Radioisotopes Market Snippet by Imaging Modality
    • 2.1.4.Diagnostic Radioisotopes Market Snippet by End-User
    • 2.1.5.Diagnostic Radioisotopes Market Snippet by Country
    • 2.1.6.Diagnostic Radioisotopes Market Snippet by Region
  • 2.2.Competitive Insights

3.Diagnostic Radioisotopes Key Market Trends

  • 3.1.Diagnostic Radioisotopes Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Diagnostic Radioisotopes Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Diagnostic Radioisotopes Market Opportunities
  • 3.4.Diagnostic Radioisotopes Market Future Trends

4.Diagnostic Radioisotopes Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Diagnostic Radioisotopes Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Diagnostic Radioisotopes Market Landscape

  • 6.1.Diagnostic Radioisotopes Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Diagnostic Radioisotopes Market - By Radioisotope

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Radioisotope, 2023 & 2032 (%)
    • 7.1.2.Technetium-99m
    • 7.1.3.Thallium-201
    • 7.1.4.Gallium-67
    • 7.1.5.Iodine-123
    • 7.1.6.FDG
    • 7.1.7.Rubidium-82
    • 7.1.8.Others

8.Diagnostic Radioisotopes Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Oncology
    • 8.1.3.Cardiology
    • 8.1.4.Other

9.Diagnostic Radioisotopes Market - By Imaging Modality

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Imaging Modality, 2023 & 2032 (%)
    • 9.1.2.SPECT
    • 9.1.3.PET
    • 9.1.4.Beta Emitters

10.Diagnostic Radioisotopes Market - By End-User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2.Hospitals
    • 10.1.3.Specialty Clinics
    • 10.1.4.Diagnostic Centers
    • 10.1.5.Academic & Research Institutes
    • 10.1.6.Others

11.Diagnostic Radioisotopes Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Diagnostic Radioisotopes Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Diagnostic Radioisotopes Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Diagnostic Radioisotopes Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Diagnostic Radioisotopes Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Diagnostic Radioisotopes Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Diagnostic Radioisotopes Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.GE Healthcare
    • 12.2.2.Siemens Healthineers
    • 12.2.3.Koninklijke Philips N.V.
    • 12.2.4.Cardinal Health
    • 12.2.5. Lantheus Holdings, Inc.
    • 12.2.6.Bayer AG
    • 12.2.7.Bracco
    • 12.2.8. Eckert & Ziegler
    • 12.2.9.Nordion (Canada) Inc.
    • 12.2.10.NTP Radioisotopes
    • 12.2.11.Curium, Jubilant Life Sciences Ltd
    • 12.2.12.Isotopia Molecular Imaging Ltd.
    • 12.2.13.Mallinckrodt Nuclear Medicine LLC
    • 12.2.14.Jubilant DraxImage Inc.
    • 12.2.15.Sumitomo Heavy Industries, Ltd.
    • 12.2.16.Telix Pharmaceuticals Limited
    • 12.2.17.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Diagnostic Radioisotopes Market: Radioisotope Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Radioisotope
  • TABLE Global Diagnostic Radioisotopes Market, by Radioisotope 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Diagnostic Radioisotopes Market, by Application 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: Imaging Modality Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Imaging Modality
  • TABLE Global Diagnostic Radioisotopes Market, by Imaging Modality 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Diagnostic Radioisotopes Market, by End-User 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Diagnostic Radioisotopes Market, by Region 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)